Welcome to our dedicated page for BlackRock ESG Capital Allocation Term Trust SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock ESG Capital Allocation Term Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock ESG Capital Allocation Term Trust's regulatory disclosures and financial reporting.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported two sales of ECAT common stock. On February 3, 2026, it sold 143,707 shares at $15.38 per share, leaving 24,824,510 shares indirectly beneficially owned. On February 4, 2026, it sold another 151,192 shares at $15.28 per share, leaving 24,673,318 shares indirectly beneficially owned.
BlackRock ESG Capital Allocation Term Trust portfolio manager Sarah Croughan Thompson reported a routine equity award vesting and sale. On January 30, 2026, 642.3734 phantom shares were converted into the same number of common shares at $0.00 per share and then 642.3734 common shares were sold at $15.44 per share, leaving her with no directly held common stock.
The filing shows she continues to hold 1,284.7468 phantom shares, which are the economic equivalent of common stock but are payable in cash, subject to vesting conditions that occur in three equal annual installments from the original January 31, 2025 grant.
BlackRock ESG Capital Allocation Term Trust (ECAT) portfolio manager Randy William Berkowitz reported a small insider transaction involving common stock and phantom shares. On January 30, 2026, he converted 659.337 phantom shares into 659.337 shares of common stock at an exercise price of $0.00 per share.
That same day, he disposed of 659.337 common shares at a price of $15.44 per share, leaving him with 0.0000 common shares directly owned. After the transaction, he continued to hold 1,318.6741 phantom shares, which are cash-settled instruments economically equivalent to common stock and payable in cash upon vesting.
BlackRock ESG Capital Allocation Term Trust (ECAT) portfolio manager Russell Jared Koesterich reported a Form 4 transaction on January 30, 2026. He acquired 5,134.5632 shares of common stock through the exercise of phantom share awards at $0.00 per share, then disposed of the same 5,134.5632 shares at $15.44 per share, leaving him with 0 common shares directly owned.
The filing also shows activity in cash-settled phantom shares, which are the economic equivalent of common stock and become payable in cash after vesting. One block of 3,160.7265 phantom shares relates to a January 31, 2025 grant that vests in three equal annual installments, with 6,321.453 phantom shares remaining. A second block of 1,973.8367 phantom shares comes from a January 31, 2024 grant with similar three-year vesting, all held as direct beneficial ownership.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On February 2, 2026, it sold 178,239 common shares at $15.55 per share in an open-market transaction coded as a sale.
After this transaction, Saba Capital Management, L.P. beneficially owned 24,968,217 ECAT common shares, held indirectly. The filing reflects an adjustment to an existing large position rather than an initial purchase or complete exit.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported selling common stock in two January transactions.
It sold 166,027 shares at $15.44 on January 29 and 157,827 shares at $15.46 on January 30. After these indirect sales, it still beneficially owned 25,146,456 common shares.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two transactions. On January 27, 2026, it sold 83,984 shares at $15.54 per share. On January 28, 2026, it sold a further 105,896 shares at $15.53 per share. After these sales, Saba Capital Management, L.P. reported 25,470,310 ECAT shares beneficially owned indirectly.
Saba Capital Management, L.P., a more than 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a routine share sale. On January 26, 2026, the firm sold 44,054 shares of ECAT common stock at a price of $15.54 per share, coded as a sale transaction.
After this trade, Saba Capital Management, L.P. reported indirect beneficial ownership of 25,660,190 ECAT common shares. The filing lists the ownership form as indirect, without specifying a particular intermediary entity in the ownership description.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open‑market sales of common stock. On January 22, 2026, Saba sold 35,831 ECAT shares at $15.50 per share. On January 23, 2026, it sold an additional 58,213 shares at $15.50 per share. After these transactions, Saba reported indirect beneficial ownership of 25,704,244 ECAT common shares.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares of the fund in two January transactions. On January 20, 2026, it sold 102,837 common shares at $15.39 per share, leaving 25,968,064 shares beneficially owned on an indirect basis. On January 21, 2026, it sold a further 169,776 common shares at $15.38 per share, after which it beneficially owned 25,798,288 common shares, also reported as indirect ownership.